How Is Eye Cancer Diagnosed? Eye Tumor Tests, Scans and Biopsy Explained

How is eye cancer diagnosed? For most tumors inside the eye, the answer is: usually without a biopsy. Because the inside of the eye can be seen and scanned directly, an ocular oncologist can often recognize a melanoma, a retinoblastoma or a harmless lookalike from its appearance and measurements on a series of imaging tests. Biopsies still have an important place, but they are used selectively.

This page explains what each test shows, when a biopsy is needed, what genetic tests add, and which files to send if you would like a specialist to review your case from abroad.

How is eye cancer diagnosed, step by step?

1. History and vision. Symptoms, previous cancers, family history and general health are recorded; vision and eye pressure are measured.
2. Dilated examination. Drops widen the pupil so the whole retina and choroid can be examined; tumors at the front of the eye are examined with a slit-lamp microscope.
3. Imaging. Photographs, ultrasound and OCT form the core; autofluorescence, angiography, anterior segment imaging or MRI are added as needed.
4. Biopsy, if needed. A sample is taken only when the result would change the diagnosis or management.
5. Staging. For malignant tumors, body scans look for spread — in uveal melanoma usually liver imaging; spread is found at diagnosis in only about 2–3% of patients.
6. Explanation and plan. The findings are explained, together with a plan for treatment or monitoring.

Young children are usually examined under a short general anesthetic (examination under anesthesia).

Which tests are used, and what does each show?

Ocular ultrasound: the key measurement

Ultrasound measures thickness and base diameter to a fraction of a millimeter — numbers that guide the choice between observation, laser, plaque brachytherapy and other treatments. The echo pattern also helps identify the tumor: melanomas typically show low to medium internal reflectivity ("acoustic hollowness") and a dome or mushroom shape, choroidal hemangiomas reflect strongly, and calcium in retinoblastoma produces bright echoes with shadowing that are essentially diagnostic. Ultrasound biomicroscopy shows the iris and ciliary body in detail and readily tells a cyst from a solid tumor.

OCT, including hand-held OCT for children

Optical coherence tomography produces microscopic cross-sections of the retina and choroid. It detects fluid under the retina — present in about 92% of small melanomas — and photoreceptor changes that help separate a small melanoma from a choroidal nevus, and after radiotherapy it picks up radiation maculopathy early. Hand-held OCT brings the same imaging to infants and young children and can reveal small retinoblastomas not yet visible on examination. OCT angiography shows blood flow without dye but remains an add-on rather than a stand-alone diagnostic test.

At the front of the eye, high-resolution OCT acts as an "optical biopsy" for ocular surface squamous neoplasia: an abnormally thick, bright surface layer with an abrupt edge (typically over about 140 µm) has shown 94–100% sensitivity and 100% specificity in published series.

Autofluorescence and angiography

Fundus autofluorescence records the natural glow of certain pigments; orange pigment (lipofuscin) glows brightly and is a risk factor that a nevus may be turning into melanoma. In fluorescein and indocyanine green (ICG) angiography, a dye injected into an arm vein is photographed as it passes through the eye, showing a tumor's own vessels — some melanomas have a "double circulation" — and leakage. On ICG, a choroidal hemangioma lights up early and then "washes out", which helps separate it from an amelanotic melanoma or a metastasis.

MRI and CT

MRI shows whether a tumor extends through the eye wall or into the orbit or optic nerve, and in retinoblastoma it examines the optic nerves and brain. CT is avoided in children with retinoblastoma, because radiation increases the risk of later cancers in those with an inherited RB1 change. For tumors in the eye socket, CT shows bone and calcium, while MRI shows soft tissue and nerves (see orbital tumors).

When is a biopsy needed?

A biopsy is considered when the diagnosis remains uncertain after imaging, when a tumor may be a metastasis or lymphoma, and when tumor cells are needed for genetic testing.

• Fine-needle aspiration biopsy (FNAB) uses a very fine needle (25–27 gauge) through the eye wall or the vitreous, often at the time of plaque placement. Diagnostic reliability is about 88–95%, with false-negative results in about 3–7%. Temporary bleeding and retinal detachment are possible; spread of tumor cells along the needle is rare.
• Vitreous biopsy is the key test for suspected intraocular lymphoma. Cytology alone is conclusive in only about 48%, so the sample also undergoes flow cytometry, gene testing (the MYD88 L265P mutation is found in up to about 87%) and cytokine measurement, where an IL-10 to IL-6 ratio above 1 suggests lymphoma.
• Surface and orbital tumors are sampled by removing a small lesion completely (excisional biopsy) or part of a larger one (incisional biopsy).
• Impression cytology collects surface cells with a small filter pressed on the eye. It is non-invasive but samples only the outermost layer, so it cannot show how deep a tumor has grown.
• Retinoblastoma is not biopsied directly, because of the risk of spreading tumor cells outside the eye; testing tumor DNA in fluid from the front of the eye (aqueous "liquid biopsy") is an emerging alternative.

What do genetic and prognostic tests add?

In uveal melanoma, genetic analysis of biopsy cells estimates the risk of spread: with the gene expression test, the 5-year risk of metastasis is about 2% for Class 1A, 21% for Class 1B and 72% for Class 2 tumors. It guides how often body scans are needed (see genetic testing and biopsy). Inherited (germline) tests use a blood sample: RB1 testing is recommended for every child with retinoblastoma, and BAP1 testing is considered for people with uveal melanoma and a personal or family history of related cancers.

What should you send for a remote second opinion?

Original files are far more useful than screenshots or phone photos of a screen, and older images matter because growth is one of the most important signs.

Add a short summary in English or Turkish (age, symptoms, affected eye, previous cancers, family history, medications) and label each file with the date and the eye. The full process is described on the second opinion page; a remote review will also say when an examination, a new scan or a biopsy is needed in person.

Eye tumor diagnosis with Prof. Türkoğlu in Antalya

Prof. Türkoğlu, a Professor of Ophthalmology and ocular oncologist, examines adults and children with suspected eye tumors and interprets the ultrasound, OCT and angiography images herself, drawing on more than 20 years in ophthalmology and her published imaging research. She explains the findings in plain language, discusses whether a biopsy or genetic test would change the plan, and outlines a clear next step. Examinations under anesthesia and tests that need specialized facilities are arranged together with the relevant specialist teams.